Plantsman Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 4.50 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth 337.85%
- Profit Growth 80.90%
- Ebitda 867.79%
- Net Worth 2181.88%
- Total Assets 48.40%
About Plantsman Biotech
Plantsman Biotech Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 December 2020 (Four years and two months 0 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹1.00 Cr.
Ajit Markale and Atul Sonawane serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01100MH2020PTC352579
- Company No.
352579
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Plantsman Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Markale  | Director | 25-Dec-2020 | Current |
| Atul Sonawane | Director | 25-Dec-2020 | Current |
Financial Performance of Plantsman Biotech.
Plantsman Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 337.85% increase. The company also saw a substantial improvement in profitability, with a 80.9% increase in profit. The company's net worth Soared by an impressive increase of 2181.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plantsman Biotech?
Unlock access to Plantsman Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2021 | Others | ₹7.50 M | Open |
| 07 Aug 2021 | Others | ₹2.50 M | Open |
How Many Employees Work at Plantsman Biotech?
Plantsman Biotech has a workforce of 0 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plantsman Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plantsman Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
